Social responsibility for the use of genes, genomes and biotechnology in biotechnology companies: A commentary from the bioethical viewpoint
Author(s) -
Yoshihiro Okada,
Kazuo Watanabe
Publication year - 2008
Publication title -
journal of commercial biotechnology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.107
H-Index - 17
eISSN - 1478-565X
pISSN - 1462-8732
DOI - 10.1057/jcb.2008.2
Subject(s) - bioethics , corporate social responsibility , microbiology and biotechnology , business ethics , social responsibility , gene engineering , business , genome , investor relations , biology , political science , public relations , gene , strategic management , marketing , genetics , recombinant dna
Corporate social responsibility (CSR) is discussed, targeting a broad range of industries. As yet, little work on CSR has focused on the specific situation of each industry. The biotechnology industry is unique in that companies use the genes and genomes of plants, animals, and humans, as well as biotechnology in their business. Public concern about genes and genomes centres on their inappropriate use or application in either research or business. This paper proposes a new CSR component for biotechnology companies: taking responsibility for the use of genes, genomes, and biotechnology (GGB) by adopting environmental ethics and bioethics. Environmental ethics is proposed as the ethical root of the environmental responsibility that companies take. The principles of environmental ethics are inductively reasoned from actual business activities, and towards the achievement of environmental responsibility. CSR for the use of GGB is deductively derived from the principles of bioethics and genetic ethics.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom